UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in TBPH — Theravance Biopharma, Inc.
CIK 861177
NEW YORK, NY
Position in TBPH
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$315,526
+$308,061 QoQ
Shares Held
19,441
+4772.4% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TBPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,235,213,491 across 211 Biotechnology names. TBPH ranks #134 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in TBPH
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $315,526 | 19,441 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $7,465 | 399 | Shares | Defined | 2026-02-13 | |
| 2024-12-31 | $1,411,866 | 150,039 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $947,089 | 117,505 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,177,675 | 138,877 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $578,814 | 64,528 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $725,292 | 64,528 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $530,010 | 61,415 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $635,643 | 61,415 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $666,350 | 61,415 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $729,734 | 65,039 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $734,317 | 72,418 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $656,105 | 72,418 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $714,732 | 74,763 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $819,399 | 74,154 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $477,297 | 64,500 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $928,131 | 63,921 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,240,804 | 60,794 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,080,308 | 60,794 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $642,082 | 43,428 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $911,552 | 43,428 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $781,208 | 33,804 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||